Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Sep 30, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.85%5.5B | 9.80%1.31B | 33.66%5.01B | 33.53%1.25B | 49.45%1.19B | 49.69%3.75B | 24.09%1.09B | 65.10%923.85M | 71.02%939.03M | 53.67%797.94M |
| Cost of revenue | 1.51%1.96B | 5.76%487.38M | 67.96%1.94B | 78.52%492.77M | 139.35%460.84M | 185.99%1.15B | 98.73%391.94M | 288.29%291.63M | 314.72%276.03M | 200.98%192.54M |
| Gross profit | 15.11%3.54B | 12.34%822M | 18.42%3.07B | 14.79%761.08M | 20.86%731.68M | 23.54%2.59B | 2.37%693.7M | 30.50%632.23M | 37.40%663M | 32.98%605.41M |
| Operating expense | 18.16%1.93B | 7.73%456.65M | 9.00%1.63B | 18.25%399.87M | 14.28%423.91M | 31.75%1.5B | 18.74%403.55M | 30.90%385.6M | 34.88%338.15M | 47.19%370.95M |
| Operating profit | 11.64%1.61B | 18.71%365.35M | 31.30%1.44B | 11.20%361.22M | 31.27%307.77M | 13.85%1.1B | -14.10%290.15M | 29.87%246.63M | 40.13%324.85M | 15.35%234.46M |
| Net non-operating interest income (expenses) | 67.58%-1.84M | 17.74%-1.36M | -58.60%-5.68M | -130.02%-1.39M | -195.89%-1.66M | -368.24%-3.58M | 25.66%-1.1M | -638.21%-1.32M | -348.15%-603K | -355.71%-560K |
| Non-operating interest income | 494.85%4.39M | 1.64%124K | -10.65%738K | -49.07%137K | -49.38%122K | -14.58%826K | -21.62%203K | -54.07%113K | 10.70%269K | 10.05%241K |
| Non-operating interest expense | -2.91%6.23M | -16.41%1.49M | 45.62%6.42M | 74.77%1.52M | 122.10%1.78M | 154.50%4.41M | -25.06%1.3M | --1.44M | --872K | --801K |
| Net investment income | 40.96%-699K | 51.61%-211K | 5.66%-1.18M | -233.93%-150K | 56.87%-436K | -68.01%-1.26M | -125.00%-182K | 72.73%-174K | 142.59%112K | -76.13%-1.01M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -3,352.24%-25.4M | 0 | |||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 95.66%-3.72M | -91.30%513K | -397.57%-85.81M | -52.53%11.15M | 104.83%5.9M | 80.46%28.84M | -93.75%958K | 1,626.14%1.52M | 10,924.41%23.48M | 741.81%2.88M |
| Less:Restructuring and mergern&acquisition | --0 | ---- | --7.52M | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Less:Other special charges | 120.19%3.72M | 91.30%-513K | 36.06%-18.44M | 52.53%-11.15M | -104.83%-5.9M | -80.46%-28.84M | 93.75%-958K | -1,626.14%-1.52M | -10,924.41%-23.48M | -741.81%-2.88M |
| Less:Write off | --0 | ---- | --96.73M | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 108.61%12.46M | 14.09%2.72M | -37.47%5.97M | -136.62%-798K | 18.24%2.39M | 98.67%9.55M | -36.20%3.1M | 17,484.62%2.26M | 7,882.14%2.18M | 50,525.00%2.02M |
| Income before tax | 19.25%1.61B | 16.90%367.01M | 22.48%1.35B | 5.72%370.03M | 32.04%313.96M | 12.35%1.1B | -18.18%292.92M | 17.89%223.51M | 50.88%350.02M | 17.00%237.78M |
| Income tax | 15.92%501.33M | 23.77%131.16M | 26.77%432.46M | 9.18%119.95M | 46.76%105.97M | 14.74%341.13M | -10.04%83.43M | 10.10%75.63M | 51.69%109.86M | 13.81%72.21M |
| Net income | 20.82%1.11B | 13.40%235.85M | 20.56%919.99M | 4.13%250.08M | 25.62%207.99M | 11.32%763.1M | -21.03%209.49M | 22.33%147.88M | 50.51%240.16M | 18.45%165.57M |
| Net income continuous operations | 20.82%1.11B | 13.40%235.85M | 20.56%919.99M | 4.13%250.08M | 25.62%207.99M | 11.32%763.1M | -21.03%209.49M | 22.32%147.88M | 50.51%240.16M | 18.44%165.57M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 20.82%1.11B | 13.40%235.85M | 20.56%919.99M | 4.13%250.08M | 25.62%207.99M | 11.32%763.1M | -21.03%209.49M | 22.33%147.88M | 50.51%240.16M | 18.45%165.57M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 20.82%1.11B | 13.40%235.85M | 20.56%919.99M | 4.13%250.08M | 25.62%207.99M | 11.32%763.1M | -21.03%209.49M | 22.33%147.88M | 50.51%240.16M | 18.45%165.57M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 20.85%23.42 | 13.47%4.97 | 20.52%19.38 | 4.15%5.27 | 25.50%4.38 | 11.28%16.08 | -20.93%4.42 | 21.96%3.11 | 50.60%5.06 | 18.31%3.49 |
| Diluted earnings per share | 20.85%23.42 | 13.47%4.97 | 24.39%19.38 | 10.47%5.2695 | 31.93%4.38 | 13.39%15.58 | -17.48%4.39 | 28.10%3.1 | 49.06%4.77 | 18.57%3.32 |
| Dividend per share | 15.38%7.5 | 0 | 18.18%6.5 | 0 | 0 | 83.33%5.5 | 83.33%5.5 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |